An immunohistochemical panel including ARG-1, HepPar-1, AFP and GPC-3, TTF-1, napsin-A, GATA3, CDX2, PAX5, PSA can be useful in differentiating HCC and non-HCC in most metastatic cases20,21. Here, NAPSA is linked to hepatocellular carcinoma.